Cite

HARVARD Citation

    Kutschenko, A. et al. (n.d.). Botulinum neurotoxin serotype D – A potential treatment alternative for BoNT/A and B non-responding patients. Clinical neurophysiology. 130 (6), pp. 1066-1073. [Online]. 
  
Back to record